Approval · Notice of Compliance 24748 · 2020
TEVA-LOPERAMIDE: Notice of Compliance 24748
Issued December 7, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24748
- Date
- December 7, 2020
- Company
- Teva Canada LimitedToronto, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Product monograph updates in line with the canadian reference product. labelling updates to comply with the plain language labelling requirements
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TEVA-LOPERAMIDE | Not yet assigned | — |
Medicinal ingredients
- LOPERAMIDE HCL 2 MG per TAB